Iscador

Mistletoe (Iskador mali) a preparation of Viscum album L.) off-label. Since decades Mistletoe has been used in European medicine for oncology^[1]Mistletoe lectins (e.g. Iscador Q viscotoxin) have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity^[2] ^[3]

Büssing et Ostermann (2012^[4]) found some evidence for moderate improvement of quality of life associated with Iscador treatment (Weleda^[5]). ^[6] Pine mistletoe extract (Iscador P Viscum album austriacus) can be used on equine sarcoids as safe and effective treatment.^[7]

^[8]

Links

References

References:

[1] Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study

[2] Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas

[3] Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients

[4] Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract (Iscador): A Meta-Analysis

[5] Iscador Newsletter summer 2015

[6] Quality of Life and Neutropenia in Patients with Early Stage Breast Cancer: A Randomized Pilot Study Comparing Additional Treatment with Mistletoe Extract to Chemotherapy Alone

[7] Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus)

[8] Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

Iscador

Links

References

References

Navigation menu

Search